Hims & Hers Faces Regulatory Hurdles Amid Global Expansion
Published on: March 2, 2026, 7:42 p.m. | Source: Devdiscourse
Hims & Hers Health faces scrutiny over its compounded drug sales and expansion efforts, amid regulatory challenges and litigation risks. While the company seeks international growth, regulatory actions against its weight-loss products in the U.S. threaten its business outlook. Analysts question its ability to meet future growth targets.
